Skip to Main Content

Paper Details

COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19.
Transpl Int
3
2022
COVID, COVID-19, DSA, KT, Remdesivir, SARS-CoV, SARS-CoV-, SARS-CoV-2, alloimmunity, patient, patients, remdesivir
Author NameAffiliation
Paul A GoepfertHeersink School of Medicine, University of Alabama at Birmingham
Emily B LevitanSchool of Public Health, University of Alabama at Birmingham
Frances E LundHeersink School of Medicine, University of Alabama at Birmingham
Frances E LundHeersink School of Medicine, University of Alabama at Birmingham
  • 1 - 4

Datasets

Release 1.2